JP2002523091A - 異種gタンパク質共役受容体の機能を改変する方法 - Google Patents
異種gタンパク質共役受容体の機能を改変する方法Info
- Publication number
- JP2002523091A JP2002523091A JP2000567692A JP2000567692A JP2002523091A JP 2002523091 A JP2002523091 A JP 2002523091A JP 2000567692 A JP2000567692 A JP 2000567692A JP 2000567692 A JP2000567692 A JP 2000567692A JP 2002523091 A JP2002523091 A JP 2002523091A
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- protein
- nucleic acid
- host cell
- coupled receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9870498P | 1998-09-01 | 1998-09-01 | |
| US60/098,704 | 1998-09-01 | ||
| PCT/US1999/020013 WO2000012705A2 (en) | 1998-09-01 | 1999-09-01 | Methods for improving the function of heterologous g protein-coupled receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002523091A true JP2002523091A (ja) | 2002-07-30 |
Family
ID=22270543
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000567692A Withdrawn JP2002523091A (ja) | 1998-09-01 | 1999-09-01 | 異種gタンパク質共役受容体の機能を改変する方法 |
| JP2000567691A Withdrawn JP2002523090A (ja) | 1998-09-01 | 1999-09-01 | 異種gタンパク質共役受容体の増強された機能的発現 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000567691A Withdrawn JP2002523090A (ja) | 1998-09-01 | 1999-09-01 | 異種gタンパク質共役受容体の増強された機能的発現 |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP1123391A2 (de) |
| JP (2) | JP2002523091A (de) |
| AU (2) | AU5700999A (de) |
| CA (2) | CA2344591A1 (de) |
| WO (2) | WO2000012705A2 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6528271B1 (en) | 1997-06-05 | 2003-03-04 | Duke University | Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
| US5891646A (en) | 1997-06-05 | 1999-04-06 | Duke University | Methods of assaying receptor activity and constructs useful in such methods |
| US7541151B2 (en) | 1997-06-05 | 2009-06-02 | Duke University | Single-cell biosensor for the measurement of GPCR ligands in a test sample |
| NZ521696A (en) * | 2000-04-24 | 2004-06-25 | Wyeth Corp | Transgenic animal models for diseases that are regulated by G-protein signalling |
| CA2426859A1 (en) * | 2000-10-26 | 2002-05-02 | The University Of British Columbia | A functional assay for g-protein-coupled receptors based on insect cells |
| EP1331228B1 (de) * | 2000-11-01 | 2007-03-21 | Astellas Pharma Inc. | VERFAHREN ZUM SCREENEN EINES PLäTTCHENHEMMERS |
| US7163800B2 (en) | 2000-11-03 | 2007-01-16 | Molecular Devices Corporation | Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity |
| US7018812B2 (en) | 2000-11-03 | 2006-03-28 | Duke University | Modified G-protein coupled receptors |
| DE10056899A1 (de) | 2000-11-16 | 2002-05-29 | Aventis Pharma Gmbh | Promotor zur funktionellen Charakterisierung von G-Protein gekoppelten Rezeptoren in der Hefe Saccharomyces cerevisiae |
| AU2002228844A1 (en) * | 2000-12-06 | 2002-06-18 | Deltagen, Inc. | Transgenic mice containing targeted gene disruptions |
| GB0030038D0 (en) * | 2000-12-08 | 2001-01-24 | Univ Warwick | Yeast-based assay |
| US7279324B2 (en) | 2001-01-23 | 2007-10-09 | Duke University | Nucleic acid encoding G-protein coupled receptor with modified DRY motif |
| EP1336655A1 (de) * | 2002-01-12 | 2003-08-20 | Aventis Pharma Deutschland GmbH | Verfahren zur Identifikation von konstitutiv aktiven Mutanten |
| DE10233516A1 (de) * | 2002-07-23 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Identifizierung von Substanzen |
| WO2006104254A1 (ja) * | 2005-03-29 | 2006-10-05 | Bio-Energy Corporation | レセプター結合性物質のスクリーニング方法 |
| US8354241B2 (en) | 2005-04-27 | 2013-01-15 | Arena Pharmaceuticals, Inc. | Methods for identifying a GLP-1 secretagogue |
| AU2006264649A1 (en) | 2005-06-30 | 2007-01-11 | Prosidion Limited | GPCR agonists |
| NZ571110A (en) | 2006-04-11 | 2011-03-31 | Arena Pharm Inc | Methods of using GPR119 receptor to identify Glucose-dependent Insulinotropic Peptide (GIP) secretagogue compounds useful for increasing bone mass in an individual |
| CL2008000018A1 (es) | 2007-01-04 | 2008-08-01 | Prosidion Ltd | Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci |
| EP2114933B1 (de) | 2007-01-04 | 2011-09-07 | Prosidion Ltd | Piperidin-gpcr-agonisten |
| PE20081849A1 (es) | 2007-01-04 | 2009-01-26 | Prosidion Ltd | Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr |
| GB2456236B8 (en) * | 2007-03-22 | 2009-12-09 | Heptares Therapeutics Ltd | Stable muscarinic receptor mutants |
| JP2010539152A (ja) | 2007-09-10 | 2010-12-16 | プロシディオン・リミテッド | 代謝障害の治療のための化合物 |
| GB0720390D0 (en) | 2007-10-18 | 2007-11-28 | Prosidion Ltd | G-Protein coupled receptor agonists |
| GB0720389D0 (en) | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
| EP2146210A1 (de) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Verfahren zur Verwendung eines AG-Protein-gekoppelten Rezeptors zur Identifikation von Peptid-YY (PPY)-Sekretagogen sowie Verbindungen zur Behandlung durch PYY modulierter Leiden |
| GB0904285D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| GB0904284D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| GB0904287D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| JP7422498B2 (ja) * | 2019-07-25 | 2024-01-26 | 芳武 村山 | ペプチド、細胞遊走抑制剤、細胞浸潤抑制剤、がん細胞転移抑制剤、及び医薬 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691188A (en) * | 1994-02-14 | 1997-11-25 | American Cyanamid Company | Transformed yeast cells expressing heterologous G-protein coupled receptor |
| CA2193809A1 (en) * | 1994-06-29 | 1996-01-11 | Catherine D. Strader | Modified g-protein coupled receptors |
| US6255089B1 (en) * | 1997-02-27 | 2001-07-03 | Albany Medical College | Constitutively activated serotonin receptors |
-
1999
- 1999-09-01 CA CA002344591A patent/CA2344591A1/en not_active Abandoned
- 1999-09-01 AU AU57009/99A patent/AU5700999A/en not_active Abandoned
- 1999-09-01 EP EP99944035A patent/EP1123391A2/de not_active Withdrawn
- 1999-09-01 EP EP99944033A patent/EP1112359A2/de not_active Withdrawn
- 1999-09-01 JP JP2000567692A patent/JP2002523091A/ja not_active Withdrawn
- 1999-09-01 CA CA002343046A patent/CA2343046A1/en not_active Abandoned
- 1999-09-01 AU AU57011/99A patent/AU756244B2/en not_active Ceased
- 1999-09-01 JP JP2000567691A patent/JP2002523090A/ja not_active Withdrawn
- 1999-09-01 WO PCT/US1999/020013 patent/WO2000012705A2/en not_active Ceased
- 1999-09-01 WO PCT/US1999/020011 patent/WO2000012704A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU5701199A (en) | 2000-03-21 |
| WO2000012704A9 (en) | 2000-06-08 |
| AU756244B2 (en) | 2003-01-09 |
| WO2000012704A3 (en) | 2000-11-30 |
| JP2002523090A (ja) | 2002-07-30 |
| WO2000012704A2 (en) | 2000-03-09 |
| CA2344591A1 (en) | 2000-03-09 |
| WO2000012705A9 (en) | 2000-07-13 |
| WO2000012705A3 (en) | 2000-10-05 |
| EP1123391A2 (de) | 2001-08-16 |
| CA2343046A1 (en) | 2000-03-09 |
| EP1112359A2 (de) | 2001-07-04 |
| WO2000012705A2 (en) | 2000-03-09 |
| AU5700999A (en) | 2000-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU756244B2 (en) | Methods for improving the function of heterologous G protein-coupled receptors | |
| JP5108062B2 (ja) | Gタンパク質キメラ体 | |
| PT1456346E (pt) | Novo sistema de expressão de genes induzido baseado no recetor de ecdisona / recetor x retinoide invertebrado | |
| US20080032317A1 (en) | Methods for improving the function of heterlogous G protein-coupled receptors | |
| JP2002541439A (ja) | レセプタアッセイ | |
| CA2034220A1 (en) | Expression vectors that produce steroid receptors, steroid receptor chimera, screening assays for steroid receptors and clinical assays using synthesized receptors and receptor vector | |
| JP2002522011A (ja) | Gタンパク質共役型受容体14273レセプター | |
| JP2002517195A (ja) | 2871レセプターと名付けられたgタンパク質共役型レセプター | |
| JP2002536997A (ja) | 新規なg蛋白質結合受容体の14273受容体 | |
| JP4106094B2 (ja) | クローン化グルカゴン様ペプチド2受容体 | |
| US7037656B2 (en) | Methods and compositions for identifying ligands for nuclear receptors | |
| US7759066B2 (en) | Molecule associating with intracellular C-terminal domain of receptor | |
| CA2439175C (en) | Opiate receptors | |
| US20040072157A1 (en) | Soluble chimeric G protein alpha subunits | |
| WO2002083934A1 (en) | P2yac receptor involved in platelet aggregation | |
| JP4622086B2 (ja) | エストロゲンレセプター遺伝子およびその利用 | |
| JP2000354500A (ja) | G蛋白質共役型受容体リガンドのスクリーニング法並びにg蛋白質共役型受容体のエクスプレッションクローニング法 | |
| JP2003125780A (ja) | 新規gpcr、それをコードする遺伝子及びそれらの用途 | |
| JP4161569B2 (ja) | bHLH−PAS蛋白質、その遺伝子及びそれらの利用 | |
| Wan | Differential gene regulation and subcellular localization of glucocorticoid receptor and progesterone receptor | |
| JPWO2003080668A1 (ja) | 核内受容体RXRαアイソフォーム | |
| JP2003525576A (ja) | Nt2lp、ニューロテンシン−2受容体との相同性を有する新規のgタンパク質共役型受容体 | |
| EP1261871A1 (de) | Verfahren und zusammensetzungen zum identifizieren von liganden für kernrezeptoren | |
| JP2003523193A (ja) | パーキンの活性調節に有用な組成物 | |
| WO2000061745A1 (fr) | Procede de criblage de ligand de proteine gr et procede d'expression du clonage de la proteine gr |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20061107 |